🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03711617
Recruiting Observational

Uremic Toxins and Outcomes in Chronic Kidney Disease

NCT03711617 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2018-05-01
Last updated
2024-12-03

Condition(s) studied

Chronic Kidney Diseases

Study summary

The aim of this cohort study is:

To investigate the etiology and epidemiology of comorbidities in CKD; To find out risk factors associated with the mortality of CKD; To find out uremic toxins which are related to the mortality and comorbidities of CKD; To focuse on the association between uremic toxins and inflammation, oxidative stress and nutritional status in CKD.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * age ≥18 years old; * clinically diagnosed with chronic kidney disease, according K/DOQI criteria. Exclusion Criteria: * acute kidney injury * history of kidney injury \<3 months * malignancy * pregnancy * incomplete clinical data

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Ninth People's Hospital Shanghai Shanghai Municipality Recruiting

More Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03711617 on ClinicalTrials.gov ↗ ← All trials in China